Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Holmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular Carcinoma

NCT06873269 is registered in ClinicalTrials.gov with Universitair Ziekenhuis Brussel as lead sponsor.

NCT NCT06873269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06873269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Holmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular Carcinoma
Lead sponsor
Universitair Ziekenhuis Brussel
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2025
Completion date
February 1, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis, locally advanced hepatocellular carcinoma, non-metastatic hepatocellular carcinoma